All News #Library
Biotech
Pheast Therapeutics Reveals PHST001 Phase 1A Data At AACR 2026
19 Apr 2026 //
FIRSTWORD PHARMA
Pheast Advances PHST001 Anti-CD24 Antibody into Phase 1b Combos
31 Mar 2026 //
GLOBENEWSWIRE
Pheast Therapeutics Unveils PHST001, Anti-CD24 Antibody Data
17 Mar 2026 //
PHARMIWEB
Pheast gets FDA Fast Track for PHST001 in Ovarian Cancer
03 Jun 2025 //
BUSINESSWIRE
Pheast Therapeutics Treats First Patient in PHST001 Phase 1 Trial
14 Apr 2025 //
BUSINESSWIRE
Pheast`s Preclinical Data on PHST001 Macrophage Inhibitor at SITC
07 Nov 2024 //
BUSINESSWIRE

Market Place
Sourcing Support